Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 110 of the 115 references it cites were found in a registry or an index; 22 of the 65 sources its claims cite were checked for support.
Abstract
Insulin resistance is a characteristic feature of type 2 diabetes and plays a major role in the pathogenesis of the disease (1,2). Although �-cell failure is the sine qua non for development of type 2 diabetes, skeletal muscle insulin resistance is considered to be the initiating or primary defect that is evident decades before �-cell failure and overt hyperglycemia develops (3,4). Insulin resistance is defined as a reduced response of target tissues (compared with subjects with normal glucose tolerance [NGT] without a family history of diabetes), such as the skeletal muscle, liver, and adipocytes, to
Overview
CoChat Summary
TL;DR
This review argues that skeletal muscle insulin resistance—especially impaired glycogen synthesis—is the initiating/primary defect in most type 2 diabetes, preceding β-cell failure and overt hyperglycemia. It concludes that overt diabetes requires β-cell failure to supervene, while muscle insulin resistance is already evident in normal glucose-tolerant high-risk relatives and prospective populations.
Key findings
- Skeletal muscle is the predominant site of insulin-mediated postprandial glucose uptake: under euglycemic hyperinsulinemia, ∼80% of glucose uptake occurs in skeletal muscle; leg muscle glucose uptake plateaus at ∼10 mg/kg leg weight per minute after 60 min, and in lean type 2 diabetic subjects it is reduced by ∼50% during the last hour of the insulin clamp.
- In lean NGT offspring of two type 2 diabetic parents, a two-step euglycemic clamp (20 and 40 mU/m² per min; plasma insulin ∼40 and ∼80 μU/ml) showed glucose uptake decreased by 33% and 43%, respectively; the impairment was accounted for entirely by reduced nonoxidative glucose metabolism/glycogen synthesis, with no defect in insulin suppression of hepatic glucose production.
- Prospective Pima Indian data showed both progressors and nonprogressors had a further 11–14% reduction in insulin sensitivity; nonprogressors increased insulin secretion by 30%, whereas progression to type 2 diabetes was associated with a 78% decline in the acute insulin response to intravenous glucose.
- Hyperinsulinemia itself worsens muscle insulin resistance: a 72 pmol/l (11 μU/ml) increase in plasma insulin for 72–96 h reduced insulin-stimulated glucose disposal by 30–40%, entirely via impaired nonoxidative glucose disposal; in rats, 7-day hyperinsulinemia reduced total-body glucose uptake, storage, and glycolysis by 39%, 62%, and 26%. Mitochondrial ATP production increased by 90% in NGT subjects without family history but only 5% in insulin-resistant offspring.
Methods
- Narrative review/symposium article; no primary study design or new sample. It synthesizes human studies using the euglycemic insulin clamp (described as the gold standard), indirect calorimetry, muscle biopsy, femoral/forearm catheterization, PET, NMR spectroscopy, OGTT, and prospective follow-up.
- Populations discussed include lean NGT first-degree relatives/offspring of two type 2 diabetic parents, Mexican Americans, Pima Indians, Caucasians in San Antonio, and type 2 diabetic subjects. Main analysis is qualitative synthesis of cited evidence.
Limitations
- Stated: by the time hyperglycemia is manifest, multiple abnormalities (elevated glucose, FFA, and cytokines) coexist, making it extremely difficult to separate each defect’s contribution; at initial presentation it is not possible to define which defect came first.
- Stated: it is unclear whether mitochondrial dysfunction leads to increased intramyocellular lipid and insulin resistance or increased muscle lipid leads to mitochondrial dysfunction and insulin resistance (“which is the cart and which is the horse”).
- Evident: as a narrative review, it lacks systematic search, formal quality assessment, or meta-analysis; conclusions depend on selected cited studies, and several figures are in an online appendix rather than the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 22 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In type 2 diabetes, impaired glycogen synthesis secondary to reduced glycogen synthase activity is the earliest detectable metabolic defect ( 39 – 41 ).”
What the sources say
- Not matchedcites [39] DeFronzo, 1997, Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying genes, Diabetes Rev
We searched by its title and found no matching paper.
- Partly supportedcites [40] Bogardus, 1984, Correlation between muscle glycogen synthase activity and in vivo insulin action in man, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports a correlation between muscle glycogen synthase activity and insulin-mediated glucose storage in glucose-tolerant and diabetic subjects. It hypothesizes a link between reduced enzyme activity and impaired glucose handling, but does not establish that one causes the other or that impaired glycogen synthesis is the earliest detectable metabolic defect in type 2 diabetes. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [41] Shulman, 1990, Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy, N Engl J Med source
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulin-mediated glucose uptake in skeletal muscle ( 26 ).”
What the sources say
- Partly supportedcites [26] Krook, 2000, Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients, Diabetes sourceExperimental — accuracy not yet measured
The paper’s introduction identifies IRS-1 and PI 3-kinase as components of insulin signaling involved in skeletal-muscle glucose transport. Its study summary says reduced PI 3-kinase activity may partly account for reduced insulin-stimulated glucose transport, while additional defects contribute. The cited passages do not establish a role for Akt or show that integrity of the entire pathway is essential for normal uptake. (LLM, conf=0.88)
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Multiple investigators unequivocally have demonstrated that lean NGT offspring of two parents with type 2 diabetes exhibit moderate to severe skeletal muscle insulin resistance ( 28 – 33 ).”
What the sources say
- Not checked — no full text of the sourcecites [28] Perseghin, 1997, Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study, Diabetes source
- Not checked — no full text of the sourcecites [29] Ferrannini, 2003, Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [30] Kashyap, 2004, Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes, Am J Physiol Endocrinol Metab source
- Partly supportedcites [31] Vaag, 1992, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus, J Clin Invest sourceExperimental — accuracy not yet measured
The Subjects section says the participants were nonobese, had normal oral glucose tolerance, and had at least one parent with NIDDM—not necessarily two. The Discussion reports skeletal-muscle insulin resistance but also considerable overlap with controls; it does not establish moderate-to-severe resistance in offspring of two affected parents. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [32] Gulli, 1992, The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents, Diabetes source
- Not checked — no full text of the sourcecites [33] Tripathy, 2003, Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband, Am J Physiol source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In lean insulin-resistant NGT offspring of type 2 diabetic parents, increased serine phosphorylation of IRS-1 in skeletal muscle has been documented in association with impaired activation of Akt ( 57 ) (Fig. A11).”
What the sources say
- Supportedcites [57] Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest source
The Introduction describes the offspring as young, lean, normoglycemic, and insulin-resistant. The Results report increased IRS-1 serine phosphorylation and reduced insulin-stimulated Akt phosphorylation in the offspring, and the Discussion explicitly describes these findings as associated. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This observation is of important clinical significance, since diacylglycerol, long-chain fatty acyl CoAs, and ceramides all have been shown to cause serine phosphorylation of insulin resistance and IRS-1 and lead to the development of insulin resistance in skeletal muscle ( 59 , 60 ).”
What the sources say
- Not checked — no full text of the sourcecites [59] Hotamisligil, 1996, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance, Science source
- Partly supportedcites [60] Jiang, 1999, Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion says elevated free fatty acids may impair insulin’s metabolic action and notes protein kinase C activation in skeletal muscle. It does not say that diacylglycerol, long-chain fatty acyl CoAs, or ceramides cause IRS-1 serine phosphorylation and thereby produce skeletal-muscle insulin resistance; its serine-phosphorylation discussion concerns the insulin receptor instead. Page numbers are unavailable in our copy. (LLM, conf=0.83)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims · 6 with their cited sources checked
Create a free account to see all 48 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various epidemiological and experimental studies have shown that muscle weakness, decreased muscle mass, reduced activation of glycogen synthase, and alterations in the numbers of glycolytic skeletal muscle fibers are related to, and may precede, insulin resistance, glucose intolerance, and T2D [332,333].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [333]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though pancreatic beta cell dysfunction is the main pathogenesis of type 2 diabetes mellitus, given that the uptake of postprandial glucose by skeletal muscles is approximately 80–90%, skeletal muscle IR plays a crucial role in the development and progression of diabetes mellitus [129,130].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dysregulation of these processes contributes to the pathogenesis of numerous diseases, including diabetes and obesity (DeFronzo and Tripathy, 2009; Sugden et al., 2009), mitochondrial disorders (Kerr, 2013), cardiac failure (Fillmore and Lopaschuk, 2013), neurodegenerative disorders (Cunnane et al., 2011; Yao et al., 2011), and cancer (Currie et al., 2013; Tennant et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as DeFronzo and Tripathy, 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the SM accounts for >80% of glucose uptake in the post-prandial period following an oral glucose load, with linear increases in uptake over time [17,20].”
From Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skeletal muscle is the main tissue responsible for insulin-stimulated glucose disposal and an impaired uptake is common in obesity and has substantial impact on whole-body glucose turnover.8,9”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“RESEARCH DESIGN AND METHODS — The euglycemic insulin clamp technique (5) is considered to be the gold standard for measuring insulin action in vivo.”
BackgroundSelf-citationMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“70) with insulin sensitivity measured with the euglycemic insulin clamp (9).”
MethodSelf-citationKatz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“This results in activation of downstream protein kinase B (also called Akt) and phosphorylation of Akt substrate 160 (AS160), which facilitates the translocation of GLUT4 to the sarcolemma and subsequent entry of glucose into the cell (25).”
BackgroundHotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · cited 7×
“Because the majority of type 2 diabetic subjects are obese, they also have daylong elevation of the plasma free fatty acid (FFA) concentration and increased circulating levels of inflammatory cytokines (1,2).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 2
- Pendergrass, 2007, Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals, Am J Physiol Endocrinol Metab, 292, E92, 10.1152/ajpendo.00617.2005 · DOI · Paper page
- Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest, 115, 3587, 10.1172/jci25151 · DOI · Paper page
Cited by
Items 1,201–1,300 of 2,099
The caveolae‐associated coiled‐coil protein, NECC 2, regulates insulin signalling in Adipocytes
Trávez, A., Rabanal‐Ruiz, Y., López‐Alcalá, J., Molero‐Murillo, L., Díaz‐Ruiz, A., Guzmán‐Ruiz, R., Catalán, V., Rodríguez, A., Frühbeck, G., Tinahones, F. J., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13840 · Cited by 9
“detected in individuals destined to develop T2D is insulin resistance, in which insulin action is impaired in skeletal muscle, liver and adipose tissue.(1,2) Insulin exerts its physiological actions upon binding to the insulin receptor (IR), leading to the activation of two major signalling pathways: the phosphatidyli…”
BackgroundLi, X., Li, X., Wang, G., Xu, Y., Wang, Y., Hao, R., & Ma, X. (2018) · Frontiers of Medicine · doi:10.1007/s11684-018-0662-8 · Cited by 10
Pimenta, F. S., Tose, H., Waichert, É., da Cunha, M. R. H., Campos, F. V., Vasquez, E. C., & Mauad, H. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-0988-5 · Cited by 13
Vitamin D Deficiency and Type 2 Diabetes in African Americans: The Common Denominators
Davis, S. V. (2011) · Diabetes Spectrum · doi:10.2337/diaspect.24.3.148 · Cited by 9
The Pathophysiology of Obesity
Mingrone, G., & Castagneto, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-15356-8_3 · Cited by 10
Lin, S., Jin, S., Zhou, F., Ya-zhe, H., & Zhang, M. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10559 · Cited by 10
“Patients with impaired glucose tolerance patient frequently exhibit periphery insulin resistance, impaired glucose metabo‐ lism in the muscle and adipose tissues, coupled with deficiency in insulin secretion (29,30).”
BackgroundLou, Y., Xie, Y., Jiang, Q., Huang, S., Wang, X., Wang, L., Wang, H., & Cao, S. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16016 · Cited by 9
“39,40 On the other hand, insulin production and efficiency tend to decrease in older or obese people.”
Inflammasomes and idiopathic inflammatory myopathies
Sun, R., Chu, J., & Li, P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1449969 · Cited by 8
Su, X., Rao, H., Zhao, C., Zhang, X., & Li, D. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1479980 · Cited by 18
“The association between IR and mortality risk appears to be particularly pronounced in elderly populations (8), postmenopausal women (9), and African Americans and Hispanics (10).”
Chen, Z., Zhou, Z., Deng, Q., Zou, Y., Wang, B., Huang, S., Tian, J., Zheng, L., Peng, X., & Tang, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020752 · Cited by 10
“Aging is characterized by a loss of skeletal muscle mass and a decline in skeletal muscle function.”
Mechanomedicine for Addressing Skeletal Muscle Insulin Resistance
Wang, L., Chang, L., Ma, Y., Jia, Y., Gao, B., Cui, W., & Xu, F. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf012 · Cited by 10
Xue, M., Rabbani, N., & Thornalley, P. J. (2025) · Antioxidants · doi:10.3390/antiox14080956 · Cited by 10
“…in prevention and treatment of disease where insulin resistance and hyperglycemia are risk factors—such as type 2 diabetes mellitus (T2DM) [12–14], diabetic kidney disease, diabetic retinopathy and diabetic neuropathy [15–19] and metabolic dysfunction–associated steatotic liver disease…”
Yao, N., Liu, L., Jiang, Y., Wang, D., Lu, Q., Zeng, Y., Yu, G., Ma, Q., Li, P., Liu, L., et al. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70061 · Cited by 11
“Therefore, loss of ASM could impair local T3 generation, leading to lower FT3/FT4 ratios and subsequent disturbances in glucose metabolism [39].”
Marková, I., Hüttl, M., Šťastný, J., Zapletalová, I., Kačer, P., Hönig, V., Kačerová, T., & Malínská, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-22745-1 · Cited by 10
Heat Therapy: Targeting Health, Disease, and Disability
Richey, R. E., Hyldahl, R. D., Kaiser, B. W., Geiger, P. C., Halliwill, J. R., & Minson, C. T. (2026) · Comprehensive physiology · doi:10.1002/cph4.70089 · Cited by 12
Unraveling the metabolic pathways between atherosclerosis and sarcopenia
Yu, M., Ge, L., Fu, C., & Zhao, R. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1762825 · Cited by 13
Metabolic psychiatry targeting metabolic dysregulation in mental health
Sethi, S., Berk, M., Andreazza, A. C., Mujica-Parodi, L. R., Campbell, I. H., Campbell, H., Longhitano, C., Rasgon, N., Volek, J. S., Calkin, C., et al. (2026) · Nature Mental Health · doi:10.1038/s44220-026-00609-5 · Cited by 16
Regulation of cellular anabolism by mTOR: or how I learned to stop worrying and love translation
Deaver, J. W., López, S. M., Ryan, P. J., Nghiem, P. P., Riechman, S. E., & Fluckey, J. D. (2020) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2020.11.003 · Cited by 9
Comprehensive Transcriptome Profiling of NAFLD- and NASH-Induced Skeletal Muscle Dysfunction
Guo, M., Xiang, L., Yao, J., Zhang, J., Zhu, S., Wang, D., Liu, C., Li, G., Wang, J., Gao, Y., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.851520 · Cited by 11
“Impaired functionality and metabolic disturbance in skeletal muscles are key features and even the driving forces for obesity, NAFLD, NASH, and type 2 diabetes, which is termed as “sarcopenic obesity” (12), suggesting the importance of studying the molecular signature of the skeletal muscle and the crosstalk mechanism…”
BackgroundKokaji, T., Eto, M., Hatano, A., Yugi, K., Morita, K., Ohno, S., Fujii, M., Hironaka, K., Ito, Y., Egami, R., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-17964-9 · Cited by 8
“Reduced responsiveness of skeletal muscle to insulin is one of the critical aspects of T2DM development (DeFronzo and Tripathy, 2009).”
BackgroundZarini, S., Berry, K. A. Z., KAHN, D. E., Garfield, A., Perreault, L., Kerege, A. A., & Bergman, B. C. (2023) · Diabetes · doi:10.2337/db22-1018 · Cited by 9
Moon, S. H., Dilthey, B. G., Guan, S., Sims, H. F., Pittman, S. K., Keith, A. L., Jenkins, C. M., Weihl, C. C., & Gross, R. W. (2023) · iScience · doi:10.1016/j.isci.2023.106895 · Cited by 9
“Numerous previous studies in mice and other mammals have demonstrated that abnormalities in skeletal muscle glucose utilization affect whole-body energy metabolism and insulin sensitivity.(23,24) Thus, the ability of skeletal muscle to extract circulating glucose and efficiently metabolize it to generate chemical ener…”
BackgroundDore, L., Durand, E., Bonafos, B., Chaiyut, J., Vaysse, L., Liengprayoon, S., Gaillet, S., Pessemesse, L., Lambert, K., Bertrand‐Gaday, C., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114945 · Cited by 10
Identification of myokines susceptible to improve glucose homeostasis after bariatric surgery
Orioli, L., Canouil, M., Sawadogo, K. A., Ning, L., Deldicque, L., Lause, P., de Barsy, M., Froguel, P., Loumaye, A., Deswysen, Y., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad122 · Cited by 9
Bae, J. C., Wander, P. L., Lemaître, R. N., Fretts, A. M., Sitlani, C. M., Bui, H. H., Thomas, M. K., Leonetti, D. L., Fujimoto, W. Y., Boyko, E. J., et al. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.10.026 · Cited by 9
Illesca, P., Ferreira, M. D. R., Benmelej, A., & D’Alessandro, M. E. (2024) · BioFactors · doi:10.1002/biof.2087 · Cited by 9
“35,36 Thus, the understanding of the mechanisms involved in muscle dysfunction and the discovery of new treatment targets and/or therapies are currently relevant to public health.”
Hutchinson, A. L., Liddle, D. M., Monk, J. M., David, W. L., & Robinson, L. E. (2024) · Nutrients · doi:10.3390/nu16132086 · Cited by 13
“In skeletal muscle, the primary site of insulin-stimulated glucose disposal [3,4], the infiltration of certain immune cells and their paracrine interactions (crosstalk) with myocytes, and the ectopic lipid accumulation characteristic of obesity as a result of adipose tissue (AT) dysfunction…”
BackgroundGao, Q., Jiang, Y., Song, Z., Ren, H., Kong, Y., Wang, C., Zheng, M., Shan, C., & Yang, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-67755-7 · Cited by 10
“In the early stages of T2DM, impaired glycogen synthesis in muscles is the primary cause of insulin resistance 55 .”
BackgroundShastry, A., Wilkinson, M., Miller, D. M., Kuriakose, M., Veeneman, J., Smith, M. R., Hindmarch, C. C. T., & Dunham‐Snary, K. J. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103541 · Cited by 9
“As skeletal muscle is often the first tissue to undergo insulin resistance in the formation of CMD, it presents an attractive marker to predict future susceptibility to disease based on dietary, genetic, and environmental factors [166,167].”
MAP3K1 May be a Promising Susceptibility Gene for Type 2 Diabetes Mellitus in an Iranian Population.
Torkamandi, S., Bastami, M., Ghaedi, H., moghadam, F., Mirfakhraie, R., & Omrani, M. D. (2016) · PubMed Central · Cited by 8
Betamethasone-exposed preterm birth does not impair insulin action in adult sheep
Matteo, R. M. D., Hodgson, D. J., Bianco‐Miotto, T., Nguyen, V. H., Owens, J. A., Harding, R., Allison, B. J., Polglase, G. R., Black, M. J., & Gatford, K. L. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0300 · Cited by 8
“We measured gene expression of components of the insulin signalling pathway in liver and M. vastus lateralis, as skeletal muscle accounts for >80% of insulinstimulated glucose uptake (DeFronzo & Tripathy 2009).”
MethodWu, S., & Chen, W. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14607 · Cited by 8
“SBP 131 (25) 129 (15) 138 (16) 129 (25) 0.”
Osteoclasts May Affect Glucose Uptake-Related Insulin Resistance by Secreting Resistin
Li, X., Sun, F., Lu, J., Zhang, J., Wang, J., Zhu, H., Gu, M., & Ma, J. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s316964 · Cited by 8
Janzen, N. R., Whitfield, J., Murray‐Segal, L., Kemp, B. E., Hawley, J. A., & Hoffman, N. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179616 · Cited by 8
“Skeletal muscle is the primary tissue responsible for post prandial glucose disposal [29], suggesting that skeletal muscle insulin sensitivity is maintained in DKI mice despite hyperinsulinemia and whole-body glucose intolerance.”
BackgroundLiberty, I. A., Kodim, N., Sartika, R. A. D., Trihandini, I., Tjekyan, R. M. S., Zulkarnain, Pane, M., Pratisthita, L. B., Tahapary, D. L., & Soewondo, P. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.102280 · Cited by 8
Kesharwani, D., Kumar, A., Poojary, M., Scaria, V., & Datta, M. (2021) · Bioscience Reports · doi:10.1042/bsr20210495 · Cited by 9
“By far, the earliest detectable events of insulin resistance observed even years before the onset of T2DM is impaired glycogen synthesis in the skeletal muscle as evidenced by studies on normal glucose-tolerant subjects having type 2 diabetic parents [7,15,16].”
InfluentialNeto, I. V. D. S., Nascimento, D. D. C., Prestes, J., da Fonseca, E. F., Celes, R. S., Rolnick, N. D., Barbalho, Y. G. D. S., Silva, A. D. O., Stival, M. M., de Lima, L. R., et al. (2022) · Biology · doi:10.3390/biology11040537 · Cited by 13
“This tissue accounts for more than 80% of insulinstimulated glucose uptake and has a major impact on whole-body metabolic homeostasis, and it is the main factor for diabetes mellitus development [40], suggesting that it could be relevant for the aging process.”
BackgroundThe older, the less potential benefit for type 2 diabetes from weight control
Zhou, Q., Sun, J., Wu, Z., Wu, W., Zhang, X., Pan, Q., Qi, H., Yuan, H., Shi, H., Cao, S., et al. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-02979-8 · Cited by 11
“The higher muscle mass of men, compared with women, may contribute to the lower effect of obesity on T2DM, because skeletal muscle, responsible for the majority of basal and insulin-stimulated glucose uptake, plays a critical role in regulating glucose homeostasis [32, 33].”
BackgroundSongserm, R., Kaeoboon, S., Suksungworn, R., Duangsrisai, S., & Sanevas, N. (2022) · Plant Science Today · doi:10.14719/pst.1560 · Cited by 14
“RONS have a detrimental role in aging and in various diseases, such as Alzheimer’s disease, cardiovascular diseases, cancer, diabetes, inflammatory problems, Parkinson’s disease and ischemia/reperfusion disorders (14-18).”
BackgroundExocytosis Proteins: Typical and Atypical Mechanisms of Action in Skeletal Muscle
Hwang, J. H., & Thurmond, D. C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.915509 · Cited by 11
“As skeletal muscle is responsible for ~80% of postprandial glucose uptake (3), insulin resistance in skeletal muscle severely impedes glucose disposal in patients with prediabetes and T2D (4).”
BackgroundA glucose-insulin-glucagon coupled model of the isoglycemic intravenous glucose infusion experiment
Subramanian, V., Bagger, J. I., Holst, J. J., Knop, F. K., & Vilsbøll, T. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.911616 · Cited by 10
Ye, Z., Ma, J., Liu, Y., Xu, B., Dai, X., Fu, M., Tian, T., Sui, X., Mo, F., Gao, S., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.950535 · Cited by 9
“Several studies have confirmed the IR in skeletal muscle is the initial defect in T2DM that may appear decades before βcell dysfunction and significant hyperglycemia development (DeFronzo and Tripathy, 2009; Merz and Thurmond, 2020).”
BackgroundChen, Y., Wen, W., Mai, Z., Wang, M., Chen, H., & Sun, J. M. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13435 · Cited by 9
“38,39 Therefore, people with sarcopenia, the age-related decline in muscle mass, strength, and function, are susceptible to developing T2DM, 24 nonalcoholic fatty liver disease, 40 and metabolic syndrome.”
BackgroundEpigenetic Network in Immunometabolic Disease
Geiger, M. A., Gorica, E., Mohammed, S. A., Mongelli, A., Mengozzi, A., Delfine, V., Ruschitzka, F. T., Costantino, S., & Paneni, F. (2023) · Advanced Biology · doi:10.1002/adbi.202300211 · Cited by 10
Ijuin, T., & Takenawa, T. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.11.031 · Cited by 7
de Kreutzenberg, S. V., Fadini, G. P., Boscari, F., Rossi, E., Guerra, S., Sparacino, G., Cobelli, C., Ceolotto, G., Bottero, M., & Avogaro, A. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.003582 · Cited by 8
Shrestha, S., Singh, V. K., Sarkar, S. K., Shanmugasundaram, B., Jeevaratnam, K., & Koner, B. C. (2018) · Drug and Chemical Toxicology · doi:10.1080/01480545.2018.1531881 · Cited by 8
Huang, S., Xu, Y., Peng, W., Cheng, J., Li, H., Shen, L., & Xia, L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27743 · Cited by 8
“Altered adipokines, increased circulating proinflammatory cytokines, and elevated lipotoxicity in obese patients might compromise the insulin signaling and hence IR (Brons & Vaag, 2009; DeFronzo & Tripathy, 2009; Kang et al., 2016).”
BackgroundZheng, J., Ding, J., Liao, M., Qiu, Z., Yuan, Q., Mai, W., Dai, Y., Zhang, H., Wu, H., Wang, Y., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000300r · Cited by 8
Łukaszuk, B., Mikłosz, A., Żendzian‐Piotrowska, M., Wójcik, B., Górski, J., & Chabowski, A. (2017) · Journal of Diabetes Research · doi:10.1155/2017/3437169 · Cited by 8
“In the light of the above, special interest has been placed on skeletal muscles, that is, a major contributor (even up to 80%) to postprandial glucose uptake [5, 6].”
BackgroundMazibuko-Mbeje, S. E., Dludla, P. V., Nkambule, B. B., Obonye, N., & Louw, J. (2018) · InTech eBooks · doi:10.5772/intechopen.75904 · Cited by 18
“Skeletal muscles account for more than 80% of insulin-stimulated glucose uptake [8], and using combined oral and intravenous glucose tolerance testing, Himsworth and Kerr were able to demonstrate that tissue-specific insulin sensitivity was lower in T2D individuals [9].”
BackgroundCree‐Green, M., Wiromrat, P., Stuppy, J. J., Thurston, J. E., Bergman, B. C., Baumgartner, A., Bacon, S. D., Scherzinger, A. L., Pyle, L. L., & Nadeau, K. J. (2019) · Obesity · doi:10.1002/oby.22658 · Cited by 9
“Furthermore, the higher proportion of Hispanic and black participants in the group with obesity may be biasing the IS results because both populations have higher rates of T2D (44).”
BackgroundInfluentialExercise during Pregnancy: Developmental Programming Effects and Future Directions in Humans
Krassovskaia, P. M., Chaves, A., Houmard, J. A., & Broskey, N. T. (2021) · International Journal of Sports Medicine · doi:10.1055/a-1524-2278 · Cited by 10
“The skeletal muscle is responsible for 70–80 % of postprandial glucose disposal, thus development of skeletal muscle insulin resistance is a key tenant in the pathogenesis of type 2 diabetes [126].”
BackgroundYang, H., Li, Z., Zhang, Y., Chang, Q., Jiang, J., Liu, Y., Ji, C., Chen, L., Xia, Y., & Zhao, Y. (2024) · Maturitas · doi:10.1016/j.maturitas.2024.108059 · Cited by 9
Annunziata, G., Caprio, M., Verde, L., Am, C., Camajani, E., Benvenuto, A., Paolini, B., Nicola, L. D., Aucella, F., Bellizzi, V., et al. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02446-8 · Cited by 8
Kitaghenda, F. K., Wang, J., Li, T., Hong, J., Yao, L., & Zhu, X. (2024) · Updates in Surgery · doi:10.1007/s13304-024-01977-2 · Cited by 8
“As previously shown, insulin resistance in the skeletal muscle is a significant defect in systemic insulin resistance and, thus, T2DM [25–30].”
Beyond the 9-to-5 grind: workaholism and its potential influence on human health and disease
Aziz, S., & Covington, C. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1345378 · Cited by 8
Gao, W. Q., Liu, J., Wang, J., Jin, Y. L., Yeung, S. L. A., Lam, T. H., Zhang, W. S., & Xu, L. (2024) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2024.105687 · Cited by 14
Numan, A. T., Jawad, N. K., & Fawzi, H. A. (2024) · Toxicology Research · doi:10.1093/toxres/tfae221 · Cited by 7
The Twin Cycle Hypothesis of type 2 diabetes aetiology: From concept to national NHS programme
Taylor, R. (2025) · Experimental Physiology · doi:10.1113/ep092009 · Cited by 7
“…skewed towards lower sensitivity with no cut-off of ‘normal’ or ‘abnormal’, and this characteristic appears to be largely genetic (Warram et al. 1990; Martin et al., 1992; Petersen et al., 2007) and is detectable in early life in those most likely to develop type 2 diabetes (Defronzo et al., 2009).”
Zhang, K., Wang, L., Gao, W. Q., & Guo, R. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1587165 · Cited by 11
“Skeletal muscle, accounting for approximately 80% of insulin-stimulated glucose disposal, is critical for glucose uptake and utilization (DeFronzo and Tripathy, 2009).”
Park, S., Kim, H., Shin, S., Kim, Y., Kang, Y., Cha, H.-N., Park, S., Park, S. K., & Oh, C. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01460-x · Cited by 7
Sen, I., Smith, J. A. B., Caria, E., Orlov, I. A., Savikj, M., Brady, A. J., Lian, K., Ellefsen, S., Zierath, J. R., & Krook, A. (2025) · Science Advances · doi:10.1126/sciadv.ads4371 · Cited by 8
“Skeletal muscle comprises ~ 50 % of body mass, and as the primary site for insulin-stimulated glucose disposal, impaired insulin action in this organ often presents early in type 2 diabetes pathogenesis ( 5 ).”
Metabolic and molecular regulation in skeletal muscle dysfunction and regeneration
Jin, J. B., Robinson, A., Soukup, T., Black, E., Abit, A., Hammer, S. M., Han, A., Lucas, E. A., Kim, Y., & Bae, J. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1651553 · Cited by 10
Zooravar, D. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01943-x · Cited by 9
“Skeletal muscle, in Turn, serves as the primary site for insulin-stimulated glucose uptake, normally responsible for clearing as much as 80% of glucose postprandial [31].”
Orioli, L., Thissen, J.-P., & Loumaye, A. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.106547 · Cited by 10
Xi, Y., Liang, Z., Jin, H., Jiang, Y., Tan, R., Zhang, Y., Wang, J., Sui, W., Liu, B., Zhang, H., et al. (2026) · Hepatology International · doi:10.1007/s12072-026-11064-w · Cited by 8
“…r m , l e g , t r unk ) , t h e m od e l s f u r t h e r m u t u a ll y a d j u s t e d f o r t h e o t h e r r e g i on s T a b l e 2 appendicular fat and muscle compartments, particularly in the lower limbs, are thought to contribute to peripheral insulin sensitivity and metabolic buffering [21].”
Ceramide stearic to palmitic acid ratio predicts incident diabetes
Hilvo, M., Salonurmi, T., Havulinna, A. S., Kauhanen, D., Pedersen, E. R., Tell, G. S., Meyer, K., Teeriniemi, A.-M., Laatikainen, T. K., Jousilahti, P., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4590-6 · Cited by 133
“Insulin resistance in skeletal muscle plays a major role in the development of type 2 diabetes [23], and there are mixed results for the Cer(d18:1/18:0) and Cer(d18:1/16:0) ceramides in the literature, although most studies support the importance of Cer(d18:1/18:0) in the development of insulin resistance in muscle.”
ResultWu, L., Chen, F., Liu, J., Hou, D., Li, T., Chen, Y., & Liao, Z. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.864904 · Cited by 11
“However, a recent study has shown that sarcopenia is a new complication of T2D (27), and there is a reverse causality Frontiers in Pediatrics | www.frontiersin.org 4 April 2022 | Volume 10 | Article 864904 between muscle mass and T2D in middle-aged and elderly individuals.”
BackgroundInfluentialGlucocorticoid therapy is a risk factor for cardiovascular diseases
Dzherieva, I. S., Волкова, Н. И., Davidenko, I. Y., Reshetnikov, I., Brovkina, S. S., Avakova, S. M., & Tishchenko, Y. V. (2022) · Medical Herald of the South of Russia · doi:10.21886/2219-8075-2022-13-3-93-106 · Cited by 12
Novel Muscle-Homing Peptide FGF1 Conjugate Based on AlphaFold for Type 2 Diabetes Mellitus
Zhou, J., Chen, X., Chen, Q., Pan, B., Lou, J., Jia, Z., Du, Y., Xu, W., Zhang, L., Feng, X., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c18461 · Cited by 8
Minato-Inokawa, S., Tsuboi-Kaji, A., Honda, M., Takeuchi, M., Kitaoka, K., Kurata, M., Wu, B., Kazumi, T., & Fukuo, K. (2024) · Metabolism Open · doi:10.1016/j.metop.2024.100306 · Cited by 9
“Skeletal muscle is the primary tissue responsible for insulin-dependent glucose uptake in vivo [1] and skeletal muscle insulin resistance is a hallmark of type 2 diabetes [2].”
BackgroundMann, G., & Adegoke, O. A. J. (2024) · Journal of Nutritional Science · doi:10.1017/jns.2024.66 · Cited by 10
“…insulin activities (glucose, amino acid, and fatty acid disposal) (35) and that muscle insulin resistance is a primary underlying cause for T2DM, (25) data presented here also imply that interventions that increase BCAA catabolic fl ux hold promise for prevention/management of T2DM and its…”
BackgroundLong, L., Xiong, B., Luo, Z., Yang, H., & She, Q. (2024) · Journal of Clinical Hypertension · doi:10.1111/jch.14944 · Cited by 8
Jaiswal, A. K., Kushawaha, A. K., Kumar, P., Ansari, A., Chhikara, N., Bhatt, H., Katiyar, S., Ahmad, I., Choudhury, A. D., Bhatta, R. S., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117366 · Cited by 7
Molecular dissection of the role of ACE2 in glucose homeostasis
Chhabra, K. H., Shoemaker, R., Herath, C. B., Thomas, M. C., Filipeanu, C. M., & Lazartigues, E. D. (2025) · Physiological Reviews · doi:10.1152/physrev.00027.2024 · Cited by 10
High-intensity interval training improves insulin sensitivity in individuals with prediabetes
Mensberg, P., Frandsen, C. L. B., Carl, C. S., Espersen, E., Leineweber, T. D., Larsen, E. L., Storgaard, H., Schlawitz, K., Petersen, T. H. D., Poulsen, J. N., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf004 · Cited by 10
Roles of FGF21 and irisin in obesity-related diabetes and pancreatic diseases
Xie, T., & Leung, P. S. (2020) · Journal of Pancreatology · doi:10.1097/jp9.0000000000000039 · Cited by 7
Li, Y., He, S., Li, C., Shen, K., Yang, M., Tao, W., Yang, Y., Shi, L., & Yao, Y. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.53004 · Cited by 10
“Compared with insulin secretion, insulin resistance is the basis and major feature of T2DM [1] and is an inherited defect that initiates the diabetic condition in the majority of patients with T2DM [2].”
BackgroundEmerging roles of C1Q tumor necrosis factor-related proteins in metabolic diseases
Ramanjaneya, M., Jerobin, J., Bettahi, I., Siveen, K. S., & Abou‐Samra, A. (2021) · Translational Medicine Communications · doi:10.1186/s41231-021-00083-4 · Cited by 8
“IR in skeletal muscles is an important mechanism in T2D [80].”
BackgroundJiang, X., & Wu, J. (2022) · Food & Function · doi:10.1039/d1fo02893f · Cited by 7
Prenatal EGCG consumption causes obesity and perturbs glucose homeostasis in adult mice
Ou, K., Zhang, S., Song, J., Fang, L., Xia, S., Huang, J. S., Wang, Q., & Wang, C. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109179 · Cited by 7
Reyad‐ul‐Ferdous, M., Song, Y., Zhang, H., & Pandey, V. (2022) · Journal of Saudi Chemical Society · doi:10.1016/j.jscs.2022.101571 · Cited by 7
“Although, our study only focuses on obesity and metabolic diseases via modulation of UCP1 gene expression. lipid and Dyslipidaemia were found abundantly in the liver of obese and insulin-resistant mice [51,52].”
Kitamura, N., Zhang, S., Morel, J., Nagano, U., Taworntawat, T., Hosoda, S., Nakamura, A., Ogawa, Y., Benegiamo, G., Auwerx, J. H., et al. (2023) · Obesity · doi:10.1002/oby.23705 · Cited by 8
“Histological analysis of skeletal muscle showed that mitochondria were enlarged and dysmorphic and they had multiple vacuoles in the HF group (Figure 3N, middle panel; Supporting Information Figure S3), similar to what is observed in skeletal muscle of rodents with aging, muscular dystrophy, and T2DM [33–35].”
BackgroundInfluentialExercise ameliorates skeletal muscle insulin resistance by modulating GRK4-mediated D1R expression
Tao, Y., Luo, W., Chen, Y., Chen, C., Chen, S., Li, X., Chen, K., & Zeng, C. (2023) · Clinical Science · doi:10.1042/cs20230664 · Cited by 7
Ivić, V., Zjalić, M., Blažetić, S., Fenrich, M., Labak, I., Scitovski, R., Szűcs, K. F., Ducza, E., Tábi, T., Bagaméry, F., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1181064 · Cited by 10
“Diet and antidiabetic drugs have a signi fi cant effect on the metabolic pro fi le of skeletal muscles in males but in less regard in females Skeletal muscle tissue is an insulin-dependent organ, and its insulin resistance triggers diabetes (30).”
BackgroundRondanelli, M., Barrile, G. C., Cavioni, A., Donati, P., Genovese, E., Mansueto, F., Mazzola, G., Patelli, Z., Pirola, M., Razza, C., et al. (2023) · Nutrients · doi:10.3390/nu15234943 · Cited by 11
Onion peel extracts ameliorate oxidative stress in streptozotocin-induced diabetic rats
Mrinal, P., Roy, U. K., Datta, S., Tapas, G., Harlalka, S., & Lekha, B. (2013) · Serbian Journal of Experimental and Clinical Research · doi:10.5937/sjecr14-4346 · Cited by 7
Diabetes prevention: Can insulin secretagogues do the job?
Westerhaus, B., Gosmanov, A. R., & Umpierrez, G. E. (2010) · Primary care diabetes · doi:10.1016/j.pcd.2010.11.002 · Cited by 8
“Studies on insulin secretion and action in pre-diabetes have shown that in IFG the first-phase insulin secretion is lost and insulin resistance is primarily at the level of the liver, resulting in exaggerated endogenous glucose production [10,11].”
BackgroundClinical characteristics of OGTT-derived hepatic- and muscle insulin resistance in healthy young men
Kim, M. K. (2014) · Physical Activity and Nutrition · doi:10.5717/jenb.2014.18.4.385 · Cited by 7
“muscle insulin resistance, is a characteristic of metabolic syndrome and diabetes patients [7].”
BackgroundRetractedPathogenesis of Type 2 Diabetes Mellitus
Kalin, M. F., Goncalves, M., & Fonseca, V. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-20797-1_13-1 · Cited by 10
Skrzep-Poloczek, B., Stygar, D. M., Chełmecka, E., Nabrdalik, K., Romuk, E. B., Poloczek, J., Sawczyn, T., Karcz, K. W., & Gumprecht, J. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3795070 · Cited by 6
“Some of those alterations are explained by defects in insulin signalling, glucose transport, or glycogen synthesis in skeletal muscles [29, 30].”
BackgroundTan, A. L. M., Langley, S. R., Tan, C. F., Chai, J. F., Khoo, C. M., Leow, M. K., Khoo, E. Y. H., Moreno‐Moral, A., Pravenec, M., Rotival, M., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00309 · Cited by 8
Atypical Antipsychotics and the Human Skeletal Muscle Lipidome
Burghardt, K. J., Ward, K. M., Sanders, E., Howlett, B. H., Seyoum, B., & Yi, Z. (2018) · Metabolites · doi:10.3390/metabo8040064 · Cited by 10
“The skeletal muscle is the main tissue involved in insulin-stimulated glucose uptake, and its dysfunction is thought to be a primary contributor to insulin resistance [23,24].”
BackgroundShang, L., Chen, T., Xian, J., Deng, Y., Huang, Y., Zhao, Q., Liang, G., Liang, Z., Lian, F., Wei, H., et al. (2019) · Cell Biology International · doi:10.1002/cbin.11144 · Cited by 7
“Many studies have suggested (Zierath et al., 1996; Antonescu et al., 2009; DeFronzo and Tripathy, 2009; Tabit et al. 2010) that changes in cellular GLUT4 are closely regulated by insulin and related to cellular sugar utilization.”
Consequences of Dicarbonyl Stress on Skeletal Muscle Proteins in Type 2 Diabetes
Ahmad, K., Shaikh, S., Lee, E. J., Lee, Y., & Choi, I. (2019) · Current Protein and Peptide Science · doi:10.2174/1389203720666191119100759 · Cited by 8
Asante, E. O., Sun, Y., Nilsen, T. I. L., Åsvold, B. O., Sørgjerd, E. P., & Mai, X. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035010 · Cited by 8
Graham, Z., Liu, X., Harlow, L., Pan, J., Azulai, D., Tawfeek, H. A. W., Wnek, R. D., Mattingly, A. J., Bauman, W. A., Yarrow, J. F., et al. (2020) · Neurotrauma Reports · doi:10.1089/neur.2020.0014 · Cited by 6
“7,9,10 Another risk factor is sublesional osteoporosis, which may be relevant to glucose homeostasis, because bone is a site of glucose disposal due to ongoing bone remodeling throughout the lifespan 13 (albeit less so with advancing age) and because bone produces osteocalcin, a molecule that…”
Ahmed, F., Pereira, M. J., & Aguer, C. (2021) · Environments · doi:10.3390/environments8040035 · Cited by 7
“Skeletal muscle uptakes approximately 80% of postprandial glucose disposal, therefore, is vital for the regulation of glucose homeostasis [57].”
BackgroundJung, T. W., Lee, H. J., Pyun, D. H., Kim, T. J., Bang, J. S., Song, J.-H., Shin, Y. K., El‐Aty, A. M. A., & Jeong, J. H. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111364 · Cited by 9
Metadata
- Authors
- DeFronzo, R. A., & Tripathy, D.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Tripathy, Devjit
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S157-S163
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811436
- OpenAlex
- W2170869159
- Cited by
- 2,102
- References
- 115
- Citations by year
- 2026: 149 · 2025: 188 · 2024: 187 · 2023: 161 · 2022: 200 · 2021: 199 · 2020: 161 · 2019: 146 · 2018: 166 · 2017: 132 · 2016: 119 · 2015: 99 · 2014: 72 · 2013: 54 · 2012: 29
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- skeletal muscle insulin resistance, type 2 diabetes, insulin resistance, beta-cell failure, type 2 diabetes pathogenesis, glucose tolerance, hyperglycemia
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Homeostasis, Humans, Insulin, Insulin Resistance, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.